https://www.targetedonc.com/view/improving-outcomes-in-all-ovarian-cancer-subtypes
0
0
34 words
0
Comments
In an interview with Targeted Oncology, Barbara Buttin, MD, discussed important ovarian cancer research for which results were presented during the 2023 ASCO Annual Meeting.
You are the first to view
Create an account or login to join the discussion